MARKET WIREYahoo! Finance Canada • 8h ago
Labcorp Holdings Inc. (LH) Stock Price, News, Quote & HistoryYahoo! Finance Canada report covering Labcorp Holdings Inc. (LH) market action, institutional positioning, and fundamental catalysts.
Why LH Stock slipped -1.84% Today — RQD Quant Desk Flash
$361.39 -1.84% NYSE • Live Quote vs Prior Daily Close (Synced Snapshot)
EXT / AFTER-HRS: $361.06
Labcorp Holdings Inc. (LH) earns a Roarable Rating of B (Buy) with 73/100 RQD Confidence. High-quality cash engine (29% profit margin, 8% return on capital) with steady institutional support. The company’s underlying cash engine and institutional positioning keep the composite score in the Green Buy zone.
ROARABLE B • BUY
Cap $29.86B
⚡ INSTANT AI QUANT PREVIEW • $0 FREE TIER
Click Any Pre-Computed AI Quant Specialist Briefing on LH Below — or Connect Your Own ChatGPT / Claude
🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief)
Is LH stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
▼
As of 2026-11-02, Labcorp Holdings Inc. (NYSE: LH) is rated B (Buy / BUY) by Roarable's 5-pillar RQD engine with a composite confidence score of 73/100 at a spot price of $361.39 (-1.84% 1D, market cap $29.86B). Pillar breakdown: Fundamental Cash Engine 13/20, Institutional 13F & Options Flow 18/20, Executive Insider Alignment 16/20, FRED Macro Regime Fit 12/20, and SEC Balance-Sheet Forensics 14/20. Across 1016 tracked Health Care issuers, LH ranks #55 in composite RQD confidence.
✓ Pre-computed one-to-many AI Quant brief
🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief)
How does LH compare to DGX and CNC in the Health Care sector?
▼
Within the Health Care sector (Medical Specialities), LH carries a Roarable B (73/100 RQD), trailing P/E of 34.0x, gross margin of 28.8%, and ROIC of 8.3%. By comparison, DGX (Quest Diagnostics Incorporated) holds a B+ grade (78/100 RQD, P/E 28.1x, ROIC 10.3%, cap $27.83B) and CNC (Centene Corporation) posts a C grade (63/100 RQD, P/E N/A, ROIC -31.0%, cap $33.97B). Among the 5-stock peer group, DGX leads on earnings multiple (28.1x) while ILMN leads on capital efficiency (18.2% ROIC).
✓ Pre-computed one-to-many AI Quant brief
🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief)
What are the biggest fundamental strengths and SEC risk factors for LH?
▼
Per LH's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0000920148), Labcorp Holdings Inc. generated $13.95B in revenue (+7.2% YoY), $877.0M in net income, and $1.21B in free cash flow against $18.39B in total assets and $5.08B in total debt. Key quantitative strengths: Big institutional funds and options desks are actively positioning on the bullish side.. Primary risk factors monitored: Broader market pullbacks can still drag down strong stocks in the short run.. Institutional options positioning shows a 50% call / 50% put premium split.
✓ Pre-computed one-to-many AI Quant brief
🤖 AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists — not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).
INTERACTIVE SCENARIO DECK:
EXT / AFTER-HRS: $361.06 (-0.09%)🧬 Cannibal Buyback (-1.80% YoY Shares)⚙️ Cash Engine: 13/20 (C) • 8.6% FCF Margin
Verify 90D Bucket Audit →📊 Historical Track Record: Scores of 73/100 (B) historically ranked in the Top 13% of excess returns over the next 90 days (+7.1% avg 90D alpha vs SPY • 69.0% hit rate).
Audit Bucket Track Record →RQD QUANT TACHOMETERBUY • B
2-of-3 JEV AI Jury Bullish
Cash
SEC
Whale
Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer
5-PILLAR SNOWFLAKE RADARRw B · Rk B-
Each axis scored 0–20
12M PRICE TARGET CONE+6.7% Base Target
WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for LH)Realized 20D OHLCV Swing Band: ±5.9%
Deterministic 5-Pillar Attribution (73/100 Composite)
🔍 WHY LH SCORES 73/100 (B) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag
▲ #1 Bullish Driver: Whale & Options Positioning+18/20 pts (25% of score)
20D Institutional Volume Accumulation (±5.9% realized swing band)
▲ #2 Bullish Driver: SEC 10-K Forensic Risk+16/20 pts (22% of score)
Altman Z-Score 3.58 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 8/9
▼ #1 Drag / Risk Factor: Macro Regime Fit12/20 pts (-8 pt drag)
Macro rate sensitivity & RSI-14 (76.9) create a -8 pt regime headwind
📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current
Q1 (-3Q)Grade C+$313.64+3% Next Q
65
Q2 (-2Q)Grade B-$323.13+2.5% Next Q
68
Q3 (-1Q)Grade B$331.17+9.1% Next Q
70
CurrentGrade B$361.39+7.1% Hist 90D α
73
Trajectory: C+ (65) → B (73)Full Audit →
⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)GIDEON ASHMERE // FORENSIC SHORT & KILL-SWITCH DOSSIER
⚔️ Adversarial Opposing Case: Why the LH Bull Thesis Could Fail
Even with a 73/100 (B) score, LH faces multiple-compression risk if 34.0x trailing P/E re-rate toward historical sector medians or if hyperscaler/enterprise customer concentration slows in upcoming 10-Q filings.
⚠️ Forensic Kill-Switch #1
Broader market pullbacks can still drag down strong stocks in the short run.
⚠️ Forensic Kill-Switch #2
Dilution & Margin Drag: Cannibal Buyback (-1.80% YoY Shares) — any gross margin slip below 26.3% triggers an automatic RQD downgrade.
⚠️ Forensic Kill-Switch #3
Technical & Forensic Kill-Switch: A daily close below the 50D SMA ($324.43) or 200D SMA ($288.53) invalidates the momentum regime and cuts Target Base ($385.78) toward Bear Floor ($296.34).
🎲 LIVE PREDICTION MARKET ODDS TIED TO $LH• $2.4M Crowd Pool • Kalshi / Polymarket Composite
Contract: “LH Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”
AUTOMATED RQD QUANT DESK MOVER BRIEFINGFull Market News Desk →
Why LH Stock slipped -1.84% Today — RQD Quant Desk Flash
Labcorp Holdings Inc. (LH) slipped -1.84% to $361.39, trading at 92% of its 52-week range ($244.52 – $371). High-quality cash engine (29% profit margin, 8% return on capital) with steady institutional support.
- ▸Technical Tape: Trading at 92% of its 52-week range ($244.52 – $371) with RSI-14 at 76.9 (OVERBOUGHT (>70)).
- ▸Volatility Profile: Historical 20-day realized swing band of ±5.9% around $361.39 (no active unusual options sweep snapshot on file).
- ▸Fundamental Anchor: Roarable B (Buy) backed by 28.8% gross margin and $1.2B annual free cash flow.
Live LH Headlines & Catalysts
MARKET WIRETradingKey • 11h ago
Labcorp Holdings Inc Stock (LH) Moved Up by 10.60% on Oct 28: Facts Behind the MovementTradingKey report covering Labcorp Holdings Inc. (LH) market action, institutional positioning, and fundamental catalysts.
RISK WATCHYahoo Finance • 14h ago
Labcorp (LH) Stock Shrugs Off Q3 Earnings As PAMA Risk LoomsYahoo Finance report covering Labcorp Holdings Inc. (LH) market action, institutional positioning, and fundamental catalysts.
RISK WATCHSeeking Alpha • 17h ago
Labcorp Holdings: The Optimism May Be Going Overboard (Rating Downgrade)Seeking Alpha report covering Labcorp Holdings Inc. (LH) market action, institutional positioning, and fundamental catalysts.
CATALYSTTradingView • 20h ago
LH Stock Rises on Q3 Earnings and Revenue Beat, '26 View UpTradingView report covering Labcorp Holdings Inc. (LH) market action, institutional positioning, and fundamental catalysts.
MARKET WIREYahoo Finance • 23h ago
Labcorp (LH) Stock Looks In Step With Its Cash Flow OutlookYahoo Finance report covering Labcorp Holdings Inc. (LH) market action, institutional positioning, and fundamental catalysts.
MARKET WIRESeeking Alpha • 1d ago
Labcorp to buy select assets of OPKO’s BioReference Health for up to $872MSeeking Alpha report covering Labcorp Holdings Inc. (LH) market action, institutional positioning, and fundamental catalysts.
CATALYSTTradingView • 1d ago
LH Stock Hits Record Levels, CHE Stock Surges To Over 52-Week Highs – Here’s What’s Driving Investor EnthusiasmTradingView report covering Labcorp Holdings Inc. (LH) market action, institutional positioning, and fundamental catalysts.
MARKET WIREYahoo • 3d ago
3 profitable stocks with warning signsNot all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow.
CATALYSTYahoo • 3d ago
Charles River (CRL) Stock Could Be 27% Overvalued As Preclinical FDA Collaboration StartsCharles River Laboratories International has become a talking point after a sharp multi‑year rally, which naturally raises a harder question for you as an investor: Is the current share price still grounded in the cash f
ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Quantitative Research Desk
Scheduled RQD Strong Buys & Whale Accumulation Briefing (LH Tape Review)
- ✓Breakdown of the highest-scoring RQD Green-Light breakouts across our 5,200+ rated universe
- ✓Forensic Red-Light accounting & dilution traps to review on your watchlist
- ✓Includes downloadable .ics calendar invite & nightly RQD rating-change email alerts
RQD INSIDER CLUB WAITLIST$49/YR PLANNED
Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?
LH // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +42.84%▲ ASCENDING CHANNEL
2026-11-02O $360.3H $368.2L $360.3C $361.4VOL 1.14M
RES: $373.7SUP: $317.9SMA50: $324.4SMA200: $288.5
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK
LH Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Share Count & Dilution Monitor (#25)
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
Reverse-DCF Expectations Hurdle (#30)
26.2%/yr Implied 5Y Growth
vs. +7.2% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
Ellis Vennor Setup Ledger (#33)
No active Ellis Vennor swing setup published on LH today. View full Setup Ledger →
🦋 Documented & Second-Order Butterfly Connections
Open Graph →
No direct multi-tier Butterfly edges indexed yet for LH. Explore sector supply chains on /butterfly.
AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for LH today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →
DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK
📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (LH)
Health Care Rank #55 of 1016
⚔️ DGX vs LH Full Matrix →
1. Head-to-Head Health Care Peer Comparison (LH vs. DGX, CNC, GH, ILMN)
Industry: Medical Specialities (41 Tracked Issuers)Across 1016 tracked Health Care securities in the Roarable RQD universe, Labcorp Holdings Inc. (LH) ranks #55 by composite RQD confidence (73/100, grade B) and #58 by equity capitalization ($29.86B). Within this direct 5-issuer industry benchmark cohort, DGX leads on earnings valuation at 28.1x trailing P/E, while ILMN leads on capital efficiency and profitability with 18.2% ROIC and 66.1% gross margin. DGX currently holds the highest overall quantitative score in the immediate peer group at 78/100 (B+) compared with LH at 73/100 (B).
| Ticker / Company | Roarable Grade | RQD Score | Trailing P/E | Gross Margin | ROIC | 1D Change | Market Cap | Head-to-Head |
|---|---|---|---|---|---|---|---|---|
| LH
ACTIVE
Labcorp Holdings Inc. | B | 73/100 | 34.0x | 28.8% | 8.3% | -1.84% | $29.86B | Benchmark Subject |
| DGX Quest Diagnostics Incorporated | B+ | 78/100 | 28.1x | 33.2% | 10.3% | -0.43% | $27.83B | /dgx-vs-lh → |
| CNC Centene Corporation | C | 63/100 | — | 8.1% | -31.0% | -0.25% | $33.97B | /cnc-vs-lh → |
| GH Guardant Health Inc. | D+ | 53/100 | — | 64.5% | -17.4% | -3.51% | $24.87B | /gh-vs-lh → |
| ILMN Illumina Inc. | B+ | 77/100 | 51.5x | 66.1% | 18.2% | -18.64% | $43.80B | /ilmn-vs-lh → |
2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)
SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0000920148In its most recent audited fiscal period (FY2025, filed 2025-12-31), Labcorp Holdings Inc. (LH) reported GAAP revenue of $13.95B (+7.2% vs. FY2024 revenue of $13.01B , and +14.7% cumulative change since FY2023) , GAAP net income of $877.0M, operating cash flow of $1.64B, and free cash flow of $1.21B (+10.0% YoY). On the balance sheet, LH closed FY2025 with $18.39B in total assets against $5.08B in total debt (Altman Z-Score: 3.58, Piotroski F-Score: 8/9).
| Fiscal Period | Filing Date | Revenue | Net Income | Operating Cash Flow | Free Cash Flow | Total Assets | Total Debt |
|---|---|---|---|---|---|---|---|
| FY2025 (FY) | 2025-12-31 | $13.95B | $877.0M | $1.64B | $1.21B | $18.39B | $5.08B |
| FY2024 (FY) | 2024-12-31 | $13.01B | $746.0M | $1.59B | $1.10B | $18.38B | $5.33B |
| FY2023 (FY) | 2023-12-31 | $12.16B | $418.0M | $1.33B | $780.4M | $16.42B | $3.84B |
3. LH Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)
✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLEDIs LH stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
As of 2026-11-02, Labcorp Holdings Inc. (NYSE: LH) is rated B (Buy / BUY) by Roarable's 5-pillar RQD engine with a composite confidence score of 73/100 at a spot price of $361.39 (-1.84% 1D, market cap $29.86B). Pillar breakdown: Fundamental Cash Engine 13/20, Institutional 13F & Options Flow 18/20, Executive Insider Alignment 16/20, FRED Macro Regime Fit 12/20, and SEC Balance-Sheet Forensics 14/20. Across 1016 tracked Health Care issuers, LH ranks #55 in composite RQD confidence.
How does LH compare to DGX and CNC in the Health Care sector?
Within the Health Care sector (Medical Specialities), LH carries a Roarable B (73/100 RQD), trailing P/E of 34.0x, gross margin of 28.8%, and ROIC of 8.3%. By comparison, DGX (Quest Diagnostics Incorporated) holds a B+ grade (78/100 RQD, P/E 28.1x, ROIC 10.3%, cap $27.83B) and CNC (Centene Corporation) posts a C grade (63/100 RQD, P/E N/A, ROIC -31.0%, cap $33.97B). Among the 5-stock peer group, DGX leads on earnings multiple (28.1x) while ILMN leads on capital efficiency (18.2% ROIC).
What are the biggest fundamental strengths and SEC risk factors for LH?
Per LH's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0000920148), Labcorp Holdings Inc. generated $13.95B in revenue (+7.2% YoY), $877.0M in net income, and $1.21B in free cash flow against $18.39B in total assets and $5.08B in total debt. Key quantitative strengths: Big institutional funds and options desks are actively positioning on the bullish side.. Primary risk factors monitored: Broader market pullbacks can still drag down strong stocks in the short run.. Institutional options positioning shows a 50% call / 50% put premium split.
Where is LH trading relative to its 50-day, 200-day, and 52-week technical levels?
LH last traded at $361.39 (-1.84% on volume of 773,783 shares), positioning the stock +11.39% above its 50-day simple moving average ($324.43) and +25.25% above its 200-day simple moving average ($288.53). Across its 52-week range of $244.52 to $371.00, LH sits at the 92.4% percentile with a 14-day RSI of 76.9 (OVERBOUGHT (>70)) and an implied next-earnings move of ±5.9% ($340.07 to $382.71).
LH Investor FAQ & Complete 8-Part Research Index
100% OPEN ACCESS • SEC EDGAR × CBOE × FREDWhy is LH stock moving today?
Why LH Stock slipped -1.84% Today — RQD Quant Desk Flash. High-quality cash engine (29% profit margin, 8% return on capital) with steady institutional support.
ROARABLE RATING BRIEF • RQD 73/100 (B)
✓ STAGE-C NUMBER FIREWALL VERIFIED
LH — Labcorp Holdings Inc.: What the Facts Mean to a Prospective Investor
Engine: anthropic/claude-haiku-5.5
As of: 2026-11-02T15:12:24Z
Roarable Rating Brief: What This Means to a Prospective Investor
Per the Roarable RQD rating, LH scores 73 out of 100, a letter grade of B, labeled "Roarable Buy — Good Risk/Reward." The five pillars are:
- Fundamental Cash Engine: 13 / 20 (ROIC 8.3%; FCF yield 4.04%). This is the second-weakest pillar relative to its ceiling. Cash generation is positive and reported, but the return on invested capital and free-cash-flow yield are modest for the price level shown.
- Whale 13F Flow: 18 / 20 (institutional accumulation and options positioning). This is the strongest pillar, indicating the rating model reads institutional positioning as constructive. The underlying holder detail is not in the source data, so the pillar cannot be decomposed further here.
- Insider Conviction: 14 / 20 (SEC Form 4 and Congressional PTR cluster flow). A moderately positive read on insider and congressional activity, though the individual transactions are not itemized in the source data.
- Macro Regime Fit: 12 / 20 (beta 0.96; sector sensitivity). The lowest pillar relative to its ceiling. A beta of 0.96 means the stock has historically moved roughly in line with the market, so the score reflects limited defensive or offensive asymmetry against the macro regime.
- Forensic Balance Sheet: 16 / 20 (Altman Z 3.58; Piotroski F 8/9; Debt/Equity 0.59). A strong pillar. The Altman Z of 3.58 and Piotroski F of 8 out of 9 point to financial health and improving fundamentals on the model's scale.
For a prospective investor evaluating the stock today, the upside case rests on the balance-sheet strength and institutional positioning, which together carry the score. The valuation tradeoff is material: the trailing P/E of 34 and forward P/E of 31.6 are elevated relative to the modest 8.3% ROIC and 4.04% FCF yield, so the price already embeds substantial expectations. The rating is a model output that weights these factors; it does not constitute a recommendation, and the macro-regime pillar signals that the stock's returns are not strongly insulated from broader market moves.
Snapshot
Business
Labcorp Holdings Inc. is a NYSE-listed issuer in the Health Care sector, operating in the Medical Specialities industry, per the company profile. The source data does not itemize its products, customer segments, or revenue model beyond the sector and industry classification. Not available in source data for detailed business description.
Financial Trend
| Period | Revenue | Operating Income | Net Income | EPS | FCF | Cash | Debt |
|---|---|---|---|---|---|---|---|
| FY 2025 | $13951.7M | $1384.7M | $877.0M | N/A | $1206.0M | $532.3M | $5084.6M |
| FY 2024 | $13008.9M | $1086.7M | $746.0M | N/A | $1095.9M | $1518.7M | $5331.2M |
| FY 2023 | $12161.6M | $725.6M | $418.0M | N/A | $780.4M | N/A | $3842.7M |
Per the SEC financials, revenue rose from $12161.6M in FY 2023 to $13951.7M in FY 2025, and net income rose from $418.0M to $877.0M over the same span. Market data reports a gross margin of 28.8%, an operating margin of 9.9%, and a net margin of 6.3%, with ROIC of 8.3%. The forensic balance sheet pillar cites an Altman Z-Score of 3.58 and a Piotroski F-Score of 8 out of 9. Debt was $5084.6M at FY 2025 against cash of $532.3M, and the source reports Debt/Equity of 0.59; cash declined from $1518.7M in FY 2024 to $532.3M in FY 2025 while debt was reduced slightly.
Recent Catalysts & News Wire Analysis
The news feed contains six items, all tagged to LH:
- Positive catalyst (GREEN): A TradingView report indicates LH stock rose on Q3 earnings and a revenue beat, with the 2026 view raised.
- Market wire (YELLOW): A Yahoo! Finance Canada item and a TradingKey item (reporting a 10.60% move on Oct 28) are categorized as market wire, providing price-action context without a directional signal.
- Risk watch (RED): A Yahoo Finance report states LH shrugged off Q3 earnings as PAMA risk looms, flagging the PAMA (Protecting Access to Medicare Act) lab-pricing exposure as a live concern. A Seeking Alpha item carries a rating downgrade headline, titled "The Optimism May Be Going Overboard."
- Market wire (YELLOW): A Yahoo Finance item on cash-flow outlook is categorized as market wire.
The Butterfly supply-chain graph reports no supply-chain links and no proprietary signals (supply chain: NONE). The net read is that the catalyst set is mixed: an earnings beat and raised view are offset by a named regulatory pricing risk and a downgrade.
Open Questions
- What is the specific exposure and timeline of the PAMA lab-pricing risk, and what share of revenue does it touch?
- Why did cash fall from $1518.7M in FY 2024 to $532.3M in FY 2025, and what drove the decline?
- Does the 34 trailing P/E reflect durable earnings growth, given ROIC of 8.3% and FCF yield of 4.04%?
- Who are the institutional and insider holders driving the Whale and Insider pillars, and what are the transaction sizes?
- What is the analyst consensus and price-target range, if any exists?
LH Live News Feed, Press Releases & Catalyst Wire
Real-time company headlines, analyst actions, and sector developments for Labcorp Holdings Inc. (LH) • Click "Debate This Headline" to argue it in the Roar Pit below
🟡 MARKET WIRE Yahoo! Finance Canada • 8h ago
Labcorp Holdings Inc. (LH) Stock Price, News, Quote & History Yahoo! Finance Canada report covering Labcorp Holdings Inc. (LH) market action, institutional positioning, and fundamental catalysts.
🟡 MARKET WIRE TradingKey • 11h ago
Labcorp Holdings Inc Stock (LH) Moved Up by 10.60% on Oct 28: Facts Behind the Movement TradingKey report covering Labcorp Holdings Inc. (LH) market action, institutional positioning, and fundamental catalysts.
🔴 RISK WATCH Yahoo Finance • 14h ago
Labcorp (LH) Stock Shrugs Off Q3 Earnings As PAMA Risk Looms Yahoo Finance report covering Labcorp Holdings Inc. (LH) market action, institutional positioning, and fundamental catalysts.
🔴 RISK WATCH Seeking Alpha • 17h ago
Labcorp Holdings: The Optimism May Be Going Overboard (Rating Downgrade) Seeking Alpha report covering Labcorp Holdings Inc. (LH) market action, institutional positioning, and fundamental catalysts.
🟢 CATALYST TradingView • 20h ago
LH Stock Rises on Q3 Earnings and Revenue Beat, '26 View Up TradingView report covering Labcorp Holdings Inc. (LH) market action, institutional positioning, and fundamental catalysts.
🟡 MARKET WIRE Yahoo Finance • 23h ago
Labcorp (LH) Stock Looks In Step With Its Cash Flow Outlook Yahoo Finance report covering Labcorp Holdings Inc. (LH) market action, institutional positioning, and fundamental catalysts.
🟡 MARKET WIRE Seeking Alpha • 1d ago
Labcorp to buy select assets of OPKO’s BioReference Health for up to $872M Seeking Alpha report covering Labcorp Holdings Inc. (LH) market action, institutional positioning, and fundamental catalysts.
🟢 CATALYST TradingView • 1d ago
LH Stock Hits Record Levels, CHE Stock Surges To Over 52-Week Highs – Here’s What’s Driving Investor Enthusiasm TradingView report covering Labcorp Holdings Inc. (LH) market action, institutional positioning, and fundamental catalysts.
🔥 THE ROAR PIT • LIVE COMMUNITY DEBATE
3 Active Posts & Replies
LH Bull vs. Bear Conversation Board — What's Your Call at $361.39?
🐂 67% BULLISH CONVICTION COMMUNITY TUG-OF-WAR ON LH 🐻 33% BEARISH CONVICTION
RO RoarDesk_Moderator Roarable Research Desk 🐂 BULLISH
🎯 Target: $434.43 (+18.0%)
📌 Pinned Debate 🔥 Official Bull vs. Bear Debate: Is LH (B • RQD 73/100) a Buy at $368.16?
Welcome to the LH (Labcorp Holdings Inc.) Roar Pit. Current RQD Composite is 73/100 (Roarable Buy — Good Risk/Reward) in Medical Specialities. Bulls point to operating leverage and sector positioning, while bears focus on valuation multiple compression (34.0x trailing P/E). Pick your side (🐂 Bull or 🐻 Bear) and drop your price target below.
SH ShortSeller_Dan Forensic Accounting Watch 🐻 BEARISH
🎯 Target: $287.16 (-22.0%)
Spot @ $368.16 Pump the brakes on LH — check the valuation vs. margin headwinds
Everyone in here is repeating the bull case on LH, but look at what you are paying: 34.0x trailing P/E with 28.8% gross margins. Unless Labcorp Holdings Inc. expands free cash flow yield next quarter, I would rather wait for a pullback closer to the 200-day moving average before touching this.
AL AlphaFlow_Cap Verified K Arena Trader 🐂 BULLISH
🎯 Target: $423.38 (+15.0%)
Spot @ $368.16 LH cash flow & RQD setup is being underpriced by the Street here
Looking at the 5-pillar RQD breakdown on LH, the market is fixating on short-term headline noise in Medical Specialities and ignoring the balance sheet and cash flow trajectory. At $368.16 (52-wk range $244.52 - $371.00), any beat on forward guidance forces shorts and underweight funds to chase.